These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7816411)

  • 1. Benign circumscribed breast masses. Mammographic and sonographic appearance.
    Schepps B; Scola FH; Frates RE
    Obstet Gynecol Clin North Am; 1994 Sep; 21(3):519-37. PubMed ID: 7816411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
    Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
    Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2009 Sep; 50(7):722-9. PubMed ID: 19488890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preoperative needle biopsy: an improvement in palpable breast tumors with strong indications for malignancy].
    Zonderland HM; van de Velde CJ; van de Vijver MJ; Hermans J
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1952-6. PubMed ID: 8927182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-negative breast screening assessment: what lessons can we learn?
    Burrell HC; Evans AJ; Wilson AR; Pinder SE
    Clin Radiol; 2001 May; 56(5):385-8. PubMed ID: 11384136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of palpable breast masses.
    Klein S
    Am Fam Physician; 2005 May; 71(9):1731-8. PubMed ID: 15887452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the radiologist accurately predict the adequacy of sampling when performing ultrasound-guided core biopsy of BI-RADS category 4 and 5 lesions detected on screening mammography?
    Doyle JM; O'Doherty A; Coffey L; Pender S; Hill A; Quinn C
    Clin Radiol; 2005 Sep; 60(9):999-1005. PubMed ID: 16124982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up recommendations for benign breast biopsies.
    Shin S; Schneider HB; Cole FJ; Laronga C
    Breast J; 2006; 12(5):413-7. PubMed ID: 16958957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective nonoperative management of solid breast masses.
    Dyess DL; Lorino CO; Grieco A; Ferrara JJ
    Am Surg; 1992 Jul; 58(7):435-40. PubMed ID: 1616189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mammographic stellate lesions.
    Flowers WM; Powers CI
    J Miss State Med Assoc; 1992 Oct; 33(10):359-60. PubMed ID: 1460664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ultrasonography in the management of masses of the breast.
    Teixidor HS
    Surg Gynecol Obstet; 1980 Apr; 150(4):486-90. PubMed ID: 7361233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast masses. Appropriate evaluation.
    Evans WP
    Radiol Clin North Am; 1995 Nov; 33(6):1085-108. PubMed ID: 7480658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging features of focal breast fibrosis: mammographic-pathologic correlation of noncalcified breast lesions.
    Venta LA; Wiley EL; Gabriel H; Adler YT
    AJR Am J Roentgenol; 1999 Aug; 173(2):309-16. PubMed ID: 10430125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mammographic-sonographic evaluation of breast masses.
    Teixidor HS; Kazam E
    AJR Am J Roentgenol; 1977 Mar; 128(3):409-17. PubMed ID: 402833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACR Appropriateness Criteria® on nonpalpable mammographic findings (excluding calcifications).
    Newell MS; Birdwell RL; D'Orsi CJ; Bassett LW; Mahoney MC; Bailey L; Berg WA; Harvey JA; Herman CR; Kaplan SS; Liberman L; Mendelson EB; Parikh JR; Rabinovitch R; Rosen EL; Sutherland ML
    J Am Coll Radiol; 2010 Dec; 7(12):920-30. PubMed ID: 21129682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.